Cytodyn Inc (CYDY)

[HyGro]

Since Cytodyn shareholders don't get to see real clinical trial data it must be hard to understand Gilead's impressive results.

Gilead spends the money to have clinical trials that can actually show statistically significant results and is developing an injectable and an oral for HIV combo, mono and PrEP all at once. Cytodyn can't seem to figure out how to do a trial that can meet an endpoint. That's why they are where they are -- failed GvHD, Failed ALL three CoV trials. Can't even file an BLA because the CEO is too busy trying to pump the stock for his insider trading.

Such a sad operation.